Kajiwara Kenji, Urashima Masaki, Yamagami Takuji, Kakizawa Hideaki, Matsuura Noriaki, Matsuura Akiko, Ohnari Tae, Ishikawa Masaki, Awai Kazuo
Department of Diagnostic Radiology, Hiroshima University Hospital, Hiroshima, Japan
Department of Radiology, Hiroshima City Hospital, Hiroshima, Japan.
Acta Radiol. 2014 Nov;55(9):1093-8. doi: 10.1177/0284185113512123. Epub 2013 Nov 19.
The standard technique for the transcatheter treatment of pulmonary arteriovenous malformations (PAVMs) involves deploying coils into the feeding arteries. We investigated whether venous sac embolization would also be a safe and useful treatment method.
To evaluate the safety and outcomes of venous sac embolization for PAVMs.
This study included 15 consecutive patients (1 man, 14 women; mean age, 54 years; range, 22-76 years) with 50 PAVMs who underwent 26 procedures; four had a history of earlier cerebral infarction or exertional dyspnea. We first placed 0.018-inch interlocking detachable and/or 0.018-inch or 0.010-inch Guglielmi detachable coils to prevent systemic migration from the venous sac. We then packed the sac as tightly as possible and embolized the orifice at the proximal feeding artery. We used angiographic, clinical, and computed tomography (CT) studies to evaluate the treatment outcomes and safety of these procedures. The mean follow-up was 16 months (range, 3-63 months) in 12 patients with 43 PAVMs; three patients (7 PAVMs) were lost to follow-up.
Immediate post-embolization angiography confirmed complete primary occlusion in 47 of 50 lesions (94%). Minor complications arose in two of 26 procedures (7.7%); they were abnormal electrocardiograms without symptoms during and pleurisy immediately after the procedure. During follow-up, 40 PAVMs were free of CT evidence of reperfusion. The mean partial arterial oxygen pressure increased from 75.3% ± 13.6 before embolization to 85.4% ± 16.3 after embolization (P < 0.01, t-test). Of the 12 patients who were available for follow-up, none experienced new-onset paradoxical embolization; pre-treatment exertional dyspnea was alleviated in one patient. There were no major complications.
Venous sac embolization for PAVMs might be safe and more effective with no reperfusion than the standard pulmonary arterial embolization.
经导管治疗肺动静脉畸形(PAVM)的标准技术是将线圈置入供血动脉。我们研究了静脉囊栓塞是否也是一种安全有效的治疗方法。
评估PAVM静脉囊栓塞的安全性和疗效。
本研究纳入15例连续患者(1例男性,14例女性;平均年龄54岁;范围22 - 76岁),共50处PAVM,接受了26次治疗;4例有既往脑梗死或劳力性呼吸困难病史。我们首先置入0.018英寸的联锁可脱卸和/或0.018英寸或0.010英寸的 Guglielmi 可脱卸线圈,以防止从静脉囊发生全身迁移。然后尽可能紧密地填充囊,并栓塞近端供血动脉的开口。我们使用血管造影、临床和计算机断层扫描(CT)研究来评估这些治疗的疗效和安全性。12例有43处PAVM的患者平均随访16个月(范围3 - 63个月);3例患者(7处PAVM)失访。
栓塞后即刻血管造影证实50处病变中的47处(94%)实现了完全原发性闭塞。26次治疗中有2次(7.7%)出现轻微并发症;分别为术中无症状的异常心电图和术后即刻的胸膜炎。随访期间,40处PAVM无CT显示再灌注的证据。平均动脉血氧分压从栓塞前的75.3%±13.6%升高至栓塞后的85.4%±16.3%(P < 0.01,t检验)。在12例可进行随访的患者中,无新发反常栓塞发生;1例患者治疗前的劳力性呼吸困难得到缓解。无重大并发症。
PAVM的静脉囊栓塞可能是安全的,且与标准肺动脉栓塞相比,再灌注少,更有效。